AstraZeneca Licenses Two Nektar Compounds
Monday, September 21, 2009 - 14:28
in Mathematics & Economics
Pharmaceuticals: $125 Million deal puts spotlight on drug-polymer conjugates.
Pharmaceuticals: $125 Million deal puts spotlight on drug-polymer conjugates.